IntrinsicIntrinsic
← Scroll for more →

Natures Sunshine Products Inc (NATR)

Pharmaceutical Preparations

Latest Price
$12.84
TTM P/E
12.71
Normalized P/E
18.21
TTM Div Yield
--
Fwd Div Yield
--
Book Value
9.63
P/B Ratio
1.33

Valuation metrics

adjust assumptions →
EPS: $1.06
Book value / share: $9.23
Formula: √(22.5 × EPS × BVPS)
Graham Number
$14.83
+16% upside
Norm. op. income: $20M (median of 7yr)
Tax rate: 31%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$13.17
+3% upside
Base FCF: $28M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$33.27
+159% upside
EPS: $1.06
Target P/E: 18×
Formula: EPS × P/E
P/E Fair Value
$19.08
+49% upside

Institutional Ownership

72.7% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
Wynnefield Capital Inc2.47M$53.0M14.23%--2026-06-30
BlackRock, Inc.989.0K$21.0M5.69%-75.4K2026-06-30
Dimensional Fund Advisors LP923.6K$20.0M5.31%+28.2K2026-06-30
American Century Companies Inc714.8K$15.0M4.11%+140.0K2026-06-30
Vanguard Capital Management LLC604.4K$13.0M3.48%+7.6K2026-06-30
Renaissance Technologies LLC527.6K$11.0M3.03%-4.4K2026-06-30
Geode Capital Management, LLC379.9K$8.0M2.19%+7.4K2026-06-30
Punch & Associates Investment Management, Inc.340.0K$7.0M1.96%--2026-06-30
State Street Corp326.9K$7.0M1.88%+1.1K2026-06-30
Hillsdale Investment Management Inc.304.6K$6.0M1.75%-12.3K2026-06-30
View all institutional holders →